For instance, the aberrant expression of myeloid markers such as CD13 and CD33 has been detected in precursor T-cell leukemias which may presage a poor prognosis in comparison with T-cell leukemia cases without the expression of myeloid antigens [22, 23]. The gene discussed is ANPEP; the disease is T-cell leukemia.